As of three days ago Exact Sciences’ Cologuard – the most effective, non-invasive colorectal cancer screening exam – is now included in the National Committee for Quality Assurance’s (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS). Inclusion in HEDIS means that physicians will receive quality credit for providing patients an exam given an “A” rating by the United States Preventative Services Taskforce (USPSTF). Earning quality credits is part of the overall movement towards Value Based Purchasing (VBP) that entitles providers to bonuses based on quality improvement. We applaud NCQA for its decision, marking a reaffirmation of our nation’s commitment to fight colorectal cancer – the second leading cause of cancer deaths in America.
The decision marks yet another milestone for Cologuard on its path to nationwide, first-dollar coverage that already includes becoming the first product ever to simultaneously receive FDA approval and a Medicare coverage decision, A-rated by the USPSTF, and affirmed by Medicare Advantage.